Republic Republic Republic
  • Log in
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Republic Venture Opportunities for accredited investors
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets Sharedrops Gift equity as a reward
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Republic Capital In-house Venture Capital fund Broker dealer Regulated capital services
Log in Sign up

Republic Republic Republic
Oops! We couldn’t find any results...
Can’t find a deal? Try advanced search.
Is something missing? Add your suggestion here.
  • US
  • Log in
  • Sign up
All investors
Primary market Live deals Secondary market Buy and sell Republic Note Own a piece of Republic's upside Investor Network Membership Receive exclusive discounts and benefits
Accredited only
Republic Venture Opportunities for accredited investors
Institutional
Republic Capital Multi-stage venture firm Republic Digital Crypto hedge fund
More
Wallet Manage your digital assets Mobile app Available on iOS or Android Learning center Explore investor resources FAQ Get your questions answered
Spotlight deal
Hamilton Lane Private Infrastructure Fund
Hamilton Lane Private Infrastructure Fund
Get unique access to the full spectrum of private markets with Hamilton Lane
Growth capital solutions
Capital fundraising Raise on Republic Tokenized assets Design, launch, manage tokenized assets
Sharedrops Gift equity as a reward
Web3 services
Advisory Access veteran web3 advisors Infrastructure Stake your digital assets Tokenization Deploy your assets on-chain Asset management Explore digital asset funds
Institutional services
Republic Capital In-house Venture Capital fund
Broker dealer Regulated capital services

Revero isn't accepting new investments

Revero’s deadline was April 19, 2022

Follow the company to stay updated on their progress, including future investment opportunities


Explore new investment opportunities:
View companies raising now
Campaign ended
Logo of Revero

Revero

Reversing autoimmune and other chronic diseases by addressing the root causes
Healthtech
Facebook Telegram Twitter LinkedIn
Featured image of Revero
Fully Funded
$3,000,000
Raised
3,058
Investors
Successfully funded and closed on April 19, 2022.
Invest in Revero

Open for investment

Investors in Revero also invested in these companies. View more
Logo of Eli Roth's The Horror Section

Eli Roth's The...

A brand-new independent studio from an iconic horror...

Republic Funding Portal · Reg CF
Logo of RYSE

RYSE

Smart Shades for your Smart Home - over $9mm in sale...

Capital R · Reg A+
Loading...
Pitch Updates 4 Reviews 1433
Invest Invest in Revero
Facebook Telegram Twitter LinkedIn
Closed on April 19, 2022. Information may not be up-to-date. Campaign closed on April 19, 2022. Information displayed may not be up-to-date.
Problem Solution Product Traction Customers Biz. model Market Competition Vision and strategy Funding Founders
About Team

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Revero Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Revero Crowd SAFE Revero Form C:A.pdf Revero Form C.pdf
Loading

Hear from some of the 3,058 people reserved or invested in Revero


Show more

Highlights


  • Revero treats and reverses autoimmune and other chronic diseases
  • Revero provides AI-based nutritional therapy & 24/7 in-app medical support
  • 79% of people eliminated or reduced all medications after 3 months
  • Reimbursement by health plans and employers is the main market strategy
  • CMO Shawn Baker MD is an expert in medical nutritional therapy
  • Compares favorably to competitor Livongo (acquired for $18.5B in 2020)

Problem


People who suffer from inflammatory and metabolic diseases deserve better help

Current solutions for chronic inflammatory & metabolic disease are ineffective and unsustainable, and generic solutions fail due to lack of personalization. 

Most patients only see their physicians a few times a year. They are usually given the standard advice to eat less and exercise more, and even when they follow that advice, they are usually put on more and more medications as time goes on.

Solution


Revero treats the root causes of chronic diseases

We have helped thousands of people in our community regain their health with a carnivore based elimination diet. In the future we are planning to go fully medical to reverse chronic diseases and provide AI-based nutritional therapy. We can identify and eliminate the foods that are causing the health issues for each patient, and get the same amazing results as the elimination diet without being too restrictive.

With Revero’s online platform, we are transforming the treatment of chronic diseases by providing AI-based medical nutritional therapy, continuous remote care, and behavioral support.


What our treatment entails



Why now? Why us?

Product


Reversing chronic diseases in our data-driven virtual-first clinic


Enter demographics + health conditions data

  • Patient is onboarded with a doctor, adds demographics, lifestyle, and health data
  • Our AI algorithms personalize the nutritional therapy for patient's unique characteristics 


AI-based personalized treatment + biomarkers

  • Our medical nutritional therapy removes the foods that are contributing to disease and includes optimal foods
  • We also adjust the treatment based on the patient’s biomarkers and symptoms


De-prescription of meds + biomarkers feedback

  • As patients improve, our physicians de-prescribe the medications and provide on-demand support
  • Patients can track their historical progress and get coaching and community support

Disclaimer: Revero is awaiting verification and medical trials to confirm its technology and treatment goals. It is currently not practicing medicine and makes no present claims about treating diseases. The information on this page reflects the future plans of the company. Please contact your healthcare provider for medical advice.

Traction


$400K+ ARR with 56% compound monthly growth

We launched two years ago, and organically grew to 2.8K+ paying subscribers and $400K+ in ARR. We have had 6K+ coaching sessions, and our podcast is ranked top 40 on Apple charts.


Subscription metrics

Customers


12K+ people have reported health improvements

The following is a summary of results from a health survey of 12,000 people reporting improvement in their health conditions as a result of the carnivore-based elimination diet.




Success stories


Business model


Reimbursement by health plans and employers


Go-to-market strategy

Our main go-to-market strategy is selling directly to self-insured employers to save millions on their medical claims budget, as well reimbursement from health insurance companies to save billions of dollars on their cost of medical claims. 


Subscription structure

Market


$152B serviceable
obtainable market

The serviceable addressable market is $862B globally and $608B for the US. Assuming Revero captures 25%, we will have a serviceable obtainable market of $152B in the US.

US market

  • Approximately 8M companies in the US
  • This represents about 133M employees
  • 2.3 billion people worldwide have multiple medical conditions

Competition


Revero is more effective and treats more conditions than competitors

We treat the underlying health issues
rather than just the symptoms

One of our most comparable competitors, Livongo, recently went public with a $18.5B acquisition. This shows a high demand for the product in the broader market. We are far superior to Omada and Virta (valued $2B) in both effectiveness and the range of health disorders we can treat—including diabetes, inflammatory, autoimmune conditions, and more. 


Revero is a new treatment paradigm. We treat the root pathways of diseases rather than just the symptoms.


Vision and strategy


A look into our future milestones and strategy


What's next for Revero?


Estimated financial projections

Funding


Founders


Mahsa Rostami

Co-founder & CEO

  • AI engineer, expert in healthcare AI
  • MS in Engineering, Data Science focus from Texas A&M
  • Developed deep learning AI solutions for CMS.gov that improved health services for millions of people


Shawn Baker MD

Co-founder & Chief Medical Officer

  • Orthopedic surgeon
  • Expert in medical nutritional therapy
  • Best-selling author
  • International speaker
  • World champion athlete

Deal terms


Valuation cap

$30,000,000

The maximum valuation at which your investment converts into equity shares or cash.
Learn more

Discount

0%

If a trigger event for Revero occurs, the discount provision gives investors equity shares (or equal value in cash) at a reduced price.
Learn more.

Minimum investment

$150

The smallest investment amount that Revero is accepting.
Learn more

Maximum investment

$250,000

The largest investment amount that Revero is accepting.
Learn more

Funding goal

$3M

Revero must achieve its minimum goal of $25K before the deadline. The maximum amount the offering can raise is $3M.
Learn more

Deadline
Revero needs to reach their minimum funding goal before the deadline ( ). If they don’t, all investments will be refunded.
Learn more
Type of security

Crowd SAFE

A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event. · Learn more

Nominee Lead

Chief Executive Officer of the Company (currently Mahsa Rostami)

Will direct the Nominee on certain matters like voting, amendments and conversions affecting the security.
Learn more

How it works

Documents

Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Revero Inc. View the official SEC filing and all updates:
Official SEC Logo Form C SEC.gov
Company documents
Revero Crowd SAFE Revero Form C:A.pdf Revero Form C.pdf

Bonus perks

In addition to your Crowd SAFE, you'll receive perks for investing in Revero.
456 investors
Invest
$500
Receive
  • One year free membership to our carnivore community ($180/year value)
  • Limited (144 left of 600)
765 investors
Invest
$1,000
Receive
  • Lifetime membership to the carnivore community (subject to product changes or sunset)
  • Limited (235 left of 1000)
71 investors
Invest
$3,000
Receive
  • Virtual steak and workout with Dr. Shawn Baker
  • Limited (4 left of 75)
36 investors
Invest
$5,000
Receive
  • Steak and workout with Dr. Shawn Baker at his house
  • Limited (4 left of 40)
11 investors
Invest
$7,000
Receive
  • Steak and workout with Dr. Shawn Baker at his house
  • Limited (4 left of 15)
24 investors
Invest
$10,000
Receive
  • Steak and workout with Dr. Shawn Baker at his house + San Francisco tour with Mahsa Rostami
  • Limited (6 left of 30)
6 investors
Invest
$20,000
Receive
  • Steak and workout with Dr. Shawn Baker at your location of choice
  • Limited (6 left of 12)
4 investors
Invest
$40,000
Receive
  • Steak and workout with Dr. Shawn Baker and Mahsa Rostami at your location of choice
  • Limited (4 left of 8)

About Revero

Legal Name
Revero Inc
Founded
Jul 2019
Form
Delaware Corporation
Employees
2
Website
revero.com
Social Media
Headquarters
Google Map location of of Revero
3031 Steiner Street 2 , San Francisco, CA
Headquarters
3031 Steiner Street, 2, San Francisco, CA, United States 94123

Revero Team
Everyone helping build Revero, not limited to employees

Profile picture of Mahsa Rostami
Mahsa Rostami
Co-Founder & CEO
AI engineer in Silicon Valley, expert in building AI solutions for healthcare. She has developed AI models that improved healthcare services for millions of people. Her personal health transformation inspired her to develop the Revero platform.
Profile picture of Dr. Shawn Baker MD
Dr. Shawn Baker MD
Co-Founder & Chief Medical Officer
Dr. Shawn Baker MD is an orthopedic surgeon, international speaker, best-selling author, and world champion athlete. He is a leading authority on nutritional therapy and raising awareness about how it affects chronic diseases.
Mahsa Rostami
Co-Founder & CEO
Dr. Shawn Baker MD
Co-Founder & Chief Medical Officer
Logo of Revero

Revero

Revero successfully raised $3,000,000 from 3058 investors on April 19, 2022
Profile picture of Steven Dunn
Profile picture of Aaron Poppell
Profile picture of Teddy Plumb
Profile picture of Sandy Davis
Profile picture of Victoria Morris
Steven, Aaron, Teddy, Sandy, Victoria, and 3053 others invested. 1433 Reviews
Republic

Giving everyone access to early-stage startup investing

For investors
  • Why invest
  • How it works
  • FAQ
  • Risks
  • Privacy policy
  • Accessibility
  • Cookie Preferences
  • Form CRS
For startups
  • Why raise
  • Learn
  • FAQ
  • Instruments
  • Crowd SAFE
  • Tokenized assets
Company
  • About
  • Journal
  • Events
  • Contact
  • We're hiring!
Dollar Refer a startup, get $2,500
Dollar Refer a startup, get $2,500

Invest in the app

Android app iOS app

Invest in the app

Android app iOS app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BankProv, member FDIC / member DIF. FDIC coverage only applies in the event of bank failure. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BankProv and are not guaranteed by BankProv. Terms and conditions apply.

Invest in startups using your credit card
You can invest using your credit card

Made in SF/NYC